Scott & Selber, Inc. Amgen Inc Transaction History

Scott & Selber, Inc.

$314 Million
Q2 2024

A detailed history of Scott & Selber, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Scott & Selber, Inc. holds 3,624 shares of AMGN stock, worth $1.16 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

3,624

Previous 3,599 0.69%

Holding current value

$1.16 Million

Previous $1.02 Million 10.65%

% of portfolio

0.36%

Previous 0.35%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $6,568 - $7,982	25 Added 0.69%	3,624 $1.13 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $6,184 - $7,464	-23 Reduced 0.64%	3,599 $1.02 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $5,114 - $5,769	-20 Reduced 0.55%	3,622 $1.04 Million
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $655 - $814	-3 Reduced 0.08%	3,642 $979,000
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $2,785 - $3,293	-13 Reduced 0.36%	3,645 $809,000
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $2,709 - $3,302	12 Added 0.33%	3,658 $884,000
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $1,832 - $2,328	-8 Reduced 0.22%	3,646 $958,000
Q3 2022 Oct 21, 2022	BUY	$224.46 - $253.15 $3,815 - $4,303	17 Added 0.47%	3,654 $824,000
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $9,228 - $10,269	-40 Reduced 1.09%	3,637 $885,000
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $10,744 - $11,885	-49 Reduced 1.32%	3,677 $889,000
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $741,026 - $848,037	3,726 New	3,726 $838,000
Q2 2019 Aug 01, 2019	SELL	$166.7 - $195.41 $2.48 Million - $2.9 Million	-14,848 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $6,511 - $7,339	-36 Reduced 0.24%	14,848 $2.82 Million
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $65,116 - $76,011	-365 Reduced 2.39%	14,884 $2.9 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $741 - $835	-4 Reduced 0.03%	15,249 $3.16 Million
Q2 2018 Jul 24, 2018	BUY	$166.05 - $186.51 $13,616 - $15,293	82 Added 0.54%	15,253 $2.82 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $63,705 - $74,448	-376 Reduced 2.42%	15,171 $2.59 Million
Q4 2017 Feb 01, 2018	SELL	$168.79 - $188.59 $13,334 - $14,898	-79 Reduced 0.51%	15,547 $2.7 Million
Q3 2017 Nov 06, 2017	SELL	$167.29 - $191.0 $52,194 - $59,592	-312 Reduced 1.96%	15,626 $2.91 Million
Q2 2017 Aug 08, 2017	BUY	N/A	15,938	15,938 $2.75 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scott & Selber, Inc. with notifications on news.

Account